Peer-Review Process
After submitting manuscripts through the website https://jmpas.com/manuscript, a unique manuscript number is generated, and all future communication with the author, reviewer, and editorial team is based on this manuscript number (jmpas/1001).
The Journal of Medical Pharmaceutical and Allied Sciences (JMPAS) employs a rigorous double-blind peer review process to ensure the quality and integrity of published articles. Here's a revised description of the peer review process:
1. Pre-Review Stage
Upon receipt of a new manuscript, the Editor-in-Chief conducts an initial pre-review check. This includes ensuring the manuscript is legible, complete, correctly formatted, original, within the journal's scope, and written in clear English. The manuscript is then reviewed by the Scientific Secretary and forwarded to the Specialized Editor for an initial quality assessment.
All submissions undergo plagiarism screening. Articles failing to meet these criteria may be rejected at this stage. The Editor-in-Chief also reviews pre-review decisions. This stage typically takes 5 to 7 days.
2. Reviewing Stage
Manuscripts that pass the pre-review stage proceed to formal peer review in round 1. Suitable articles are assigned to three independent expert reviewers with expertise relevant to the manuscript's subject matter.
The Editor makes the final decision on acceptance or rejection based on reviewers' comments. Authors may be invited to revise their manuscript for reconsideration in round 2 of peer review.
Editors abstain from decisions involving manuscripts they authored those by family or colleagues, or those related to their commercial interests.
The reviewing process averages 1 to 2 months, though timelines may vary.
3. Invitation to Review
Reviewers are required to disclose conflicts of interest, such as direct competition with authors, collaboration, potential for exploitation of authors' work, or any bias preventing objective assessment. Conflicts should be declared to the Editorial Office, allowing for alternative reviewer selection if necessary.
4. Reviewer Reports and Anonymity
Reviewer reports, along with decision letters, are sent to authors. Reports may be edited for clarity and to ensure the anonymity of reviewers. Reviewer identities remain confidential and are disclosed only to The Journal of Medical Pharmaceutical and Allied Sciences (JMPAS) Editorial Board members, who also maintain confidentiality.
JMPAS operates a double-blind review process, ensuring mutual anonymity between reviewers and authors throughout the review process.
5. Revised Manuscript
Authors revise manuscripts in response to reviewers' feedback. Revised manuscripts are re-reviewed by the original reviewers or new reviewers if required. Acceptance depends on reviewers' satisfaction with revisions and author responses.
6. Proofing
Accepted articles undergo proofreading, with proofs sent electronically to corresponding authors for verification. Corrections are expected within 48 hours.
This structured peer review process ensures that articles published in The Journal of Medical Pharmaceutical and Allied Sciences (JMPAS) meet high academic standards and contribute to scientific discourse effectively.